Measurable disease per FET-PET vs MRI in GBM


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 08 2025 14 mins   3

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.